AACR Annual Meeting 2019: Manipulating the Immune System in Cancer Therapy
Cancer immunotherapy research has exploded in recent years. This treatment utilizes a patient’s own immune system to recognize and...
Tag: immunotherapy
Cancer immunotherapy research has exploded in recent years. This treatment utilizes a patient’s own immune system to recognize and...
Last Friday, March 8, 2019, marked another milestone in immuno-oncology: The U.S. Food and Drug Administration (FDA) announced the...
This year, the AACR Annual Meeting, the premier cancer research meeting in the world, is happening at the Georgia...
Immune-related adverse events (irAEs) is the collective term used to describe the side effects that arise in response to...
In 2018, we witnessed significant momentum in several hot areas of cancer research, including immunotherapy and precision medicine. Researchers...
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...
Pancreatic cancer remains a challenging disease to treat, with a five-year survival rate of less than 9 percent, according...
Last week saw a flurry of new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) for...
On Monday, James P. Allison, PhD, a Fellow of the AACR Academy and a past member of the AACR’s...
As a monthly feature on this blog, we spotlight the 10 articles selected by our editors from each journal...